Beijing Sun-Novo Pharmaceutical Research Co.Ltd(688621) : the net profit in 2021 increased by 45.81% year-on-year, and it is proposed to pay 2.65 yuan per 10

Beijing Sun-Novo Pharmaceutical Research Co.Ltd(688621) ( Beijing Sun-Novo Pharmaceutical Research Co.Ltd(688621) ) released the annual report for 2021 on February 27. The company achieved an operating revenue of 494 million yuan in 2021, an increase of 42.12% year-on-year; The net profit attributable to the shareholders of the listed company was 106 million yuan, a year-on-year increase of 45.81%; The basic earnings per share is 1.51 yuan. It is proposed to distribute a cash dividend of 2.65 yuan (including tax) to all shareholders for every 10 shares.